BioNTech
BioNTech’s melanoma vaccine shows promise in early interim analysis
July 30, 2020Research and Development BioNTech, Cancer, pharma
While the company has more recently drawn headlines for its COVID-19 efforts, BioNTech has unveiled promising interim Phase 1 data …
Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study
July 22, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma
BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …
Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate
July 3, 2020Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …
Fosun and BioNTech partner up for coronavirus vaccine development and commercialisation
March 16, 2020Research and Development, Sales and Marketing BioNTech, coronavirus, fosun, pharma
As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …
Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines
August 16, 2018Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma
Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …
Sanofi and BioNTech in cancer immunotherapy partnership
November 3, 2015Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy
Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …
European Commission funds €23m project to develop HIV vaccine
November 2, 2015Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020
The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …
BioNTech appoints chief financial officer
September 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNTech, Sierk Pötting
German biopharma firm BioNTech has announced that Sierk Pötting will be joining its management team as its chief financial officer, …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
